Andreas Behren

21PUBLICATIONS
100CO-AUTHORS
Tumour immunologyMolecular targetsPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Jul 16, 2024
Vγ9Vδ2 T cells recognize butyrophilin 2A1 and 3A1 heteromers.

Thomas S Fulford, Caroline Soliman, Rebecca G Castle

|Mar 01, 2024
A gut microbial signature for combination immune checkpoint blockade across cancer types.

Ashray Gunjur, Yan Shao, Timothy Rozday

|Oct 06, 2023
TCF-1 limits intraepithelial lymphocyte antitumor immunity in colorectal carcinoma.

Marina H Yakou, Sonia Ghilas, Kelly Tran

|Apr 08, 2022
'Know thyself' - host factors influencing cancer response to immune checkpoint inhibitors.

Ashray Gunjur, Andrea J Manrique-Rincón, Oliver Klein

|Oct 23, 2021
Identification of Tumor Antigens in Ovarian Cancers Using Local and Circulating Tumor-Specific Antibodies.

Jessica Da Gama Duarte, Luke T Quigley, Anna Rachel Young

|Apr 30, 2021
Ropporin-1 and 1B Are Widely Expressed in Human Melanoma and Evoke Strong Humoral Immune Responses.

Jessica Da Gama Duarte, Katherine Woods, Luke T Quigley

Pageof 4